CorMedix (CRMD) Net Cash Flow Growth (3y) (2015 - 2025)
CorMedix (CRMD) Net Cash Flow Growth (3y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
89.97% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-13.44% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
33.37% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
CorMedix |
631,378.03 |
-154.57 Mn |
107.31 Mn |
854.29% |
| Date | Value |
|---|
| Dec 31, 2025 |
854.29% |
| Sep 30, 2025 |
-168.61% |
| Jun 30, 2025 |
197.20% |
| Mar 31, 2025 |
73.62% |
| Dec 31, 2024 |
34.13% |
| Sep 30, 2024 |
44.16% |
| Jun 30, 2024 |
-29.07% |
| Mar 31, 2024 |
-30.96% |
| Dec 31, 2023 |
-48.63% |
| Sep 30, 2023 |
23.44% |
| Jun 30, 2023 |
-48.99% |
| Mar 31, 2023 |
-62.76% |
| Dec 31, 2022 |
69.18% |
| Sep 30, 2022 |
-44.47% |
| Jun 30, 2022 |
43.56% |
| Mar 31, 2022 |
-143.73% |
| Dec 31, 2021 |
-46.78% |
| Sep 30, 2021 |
-80.59% |
| Jun 30, 2021 |
3.31% |
| Mar 31, 2021 |
159.55% |
